Scilex enters warrant exercise agreement for $2.7M proceeds; issues new warrants for 275K shares

Scilex Holding Co

Existing warrant holders exercise 179,236 shares at net $15.00/share after $7.72 deferral fee, raising ~$2.7M.
Company will use $2.5M of proceeds to repay outstanding Tranche B Notes (senior secured convertible notes).
New September 2025 warrants issued: 275,000 shares at $20 strike, expiring Dec 13, 2029, immediately exercisable.
Holders defer Oct 1, 2025 amortization payment to Jan 1, 2026 in exchange for $7.72/share deferral fee.
Placement agents are Rodman & Renshaw and Stockblock Securities.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.95

Scilex Holding Co issued 179,236 shares of Common Stock of common stock to Existing Warrant Holders for exercise of Existing December 2024 Warrants with aggregate gross proceeds of approximately $2.7 million, net of Deferral Fee.

Security: common stock
Shares: 179,236 shares of Common Stock
Purchaser: Existing Warrant Holders
Consideration: exercise of Existing December 2024 Warrants with aggregate gross proceeds of approximately $2.7 million, net of Deferral Fee

Exact text from the filing

Pursuant to the Warrant Exercise Agreements, the Existing Warrant Holders will exercise in full the Existing December 2024 Warrants for an aggregate of 179,236 shares of Common Stock

View on SEC.gov

Browse all equity issuances →

Scilex Holding Co filing history →

Source: SEC EDGAR

accession 0001193125-25-226992

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.